Cover Image
Market Research Report

SEPSIS DIAGNOSTICS Global Markets by Assay Technology with Executive and Consultant Guides. Including Customized Forecasting and Analysis 2020 to 2024

Published by Howe Sound Research Product code 914655
Published Content info 237 Pages
Delivery time: 1-2 business days
Price
Back to Top
SEPSIS DIAGNOSTICS Global Markets by Assay Technology with Executive and Consultant Guides. Including Customized Forecasting and Analysis 2020 to 2024
Published: November 3, 2019 Content info: 237 Pages
Description

OVERVIEW:

Sepsis is killing over 30 million people a year with no definitive diagnostic in hand. The race is on using all the genomic and molecular diagnostic tools that have come to the fore in the last decade. It is not clear who will be the winner, but the stakes are global and large. Emergency life saving diagnostics can command a premium in the market. Understand what is driving this huge global diagnostic market and where the opportunity lies.

Our facts and support = Your success.

The report forecasts the market size out to 2024. Growth is coming from the basic factors but technology and education are creating the awareness needed to rapidly expand the diagnostic market. Some players have already made their mark but disruptive diagnostic technology could change the playing field.. Learn about this market including the issues and outlooks. The two key trends of Rapid Diagnositic and the Genomics Revolution are merging to create new diagnostic opportunities.

Our research makes you the expert in your organization. Get our research team working for you by ordering this comprehensive report. Your credit card order sends the report to your inbox instantly. Check all your licensing options but don't worry, your order is available as a credit if you wish to upgrade to a wider license. We wrote this report and we are ready, by phone or email, to help you use it. As always, assistance, and additional specific data, is provided without additional charges.

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.

ABOUT THE LEAD AUTHOR:

Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell's education includes:

  • B.Sc. (Chemistry) University of BC
  • M.B.A. (Finance and Policy) University of BC
  • Market Research Seminar - Burke Institute
  • Finance for Senior Executives - Harvard Business School
Table of Contents

Table of Contents

i. Market Guides

  • iA. Situation Analysis
  • iB. Guide for Executives and Marketing Staff
  • iC. Guide for Investment Analysts and Management Consultants

1. Introduction and Market Definition

  • 1.1 An Overview of Sepsis Diagnostics
    • 1.1.1 Sepsis the medical emergency
    • 1.1.2 Sepsis Diagnosis and Comorbidity
  • 1.3 Market Definition
    • 1.3.1 Market Size
    • 1.3.2 Currency
    • 1.3.3 Years
    • 1.3.4 Microbiology
    • 1.3.5 Other Infectious Disease
    • 1.3.6 Syndromic PoC
    • 1.3.7 Biomarkers Molecular Diagnostics
    • 1.3.8 Biomarkers Other
    • 1.3.9 Limitations
  • 1.4 Methodology
    • 1.4.1 Authors
    • 1.4.2 Sources
  • 1.5 U.S. Medical Market and laboratory Testing - Perspective
    • 1.4.1 U.S. Medicare Expenditures for Laboratory Testing

2. Sepsis - Current Science

  • 2.1 What is Sepsis?
    • 2.1.1 Organ Damage
    • 2.1.2 Neonatal sepsis
    • 2.1.3 Prognosis
  • 2.2 Diagnosis
    • 2.2.1 Infection Identification
    • 2.2.2 Biomarkers
    • 2.2.3 Differential diagnosis
  • 2.3 Causes of Sepsis
    • 2.3.1 Sepsis Progression
  • 2.4 Prevalence

3. Industry Overview

  • 3.1 Players in a Dynamic Market
    • 3.1.1 Academic Research Lab
    • 3.1.2 Diagnostic Test Developer
    • 3.1.3 Pharmaceutical/Reagent Supplier
    • 3.1.4 Independent Testing Lab
    • 3.1.6 Public National/regional lab
    • 3.1.7 Hospital lab
    • 3.1.8 Physician Lab
    • 3.1.9 Audit Body
    • 3.1.10 Certification Body

4. Market Trends

  • 4.1 Factors Driving Growth
    • 4.1.1 Increasing Prevalence
    • 4.1.2 Antimicrobial Resistance
    • 4.1.3 Increasing Diagnosis
    • 4.1.4 Multiplex Diagnostics Impacts
    • 4.1.5 The Aging World
    • 4.1.6 Developing World Health Care Spending
  • 4.2 Factors Limiting Growth
    • 4.2.1 The Cost Curve Shrinks the Market
    • 4.2.2 The Diagnostics Dillemma
    • 4.2.3 Adoption Lag and Cost Control
  • 4.3 Diagnostic Technology Development
    • 4.3.1 The Multiplex Opportunity
    • 4.3.2 Shifting Role of Physicians in Diagnosis
    • 4.3.3 Diagnostics Moves Out of the Lab
    • 4.3.4 Biomarkers and Algorithms
    • 4.3.5 Rapid Testing Changing Medical Practice
    • 4.3.6 Genome Role and Big Data
    • 4.3.6 The Next Five Years

5. Sepsis Diagnostics - Recent Developments

  • 5.1 Recent Developments - Importance and How to Use This Section
    • 5.1.1 Importance of These Developments
    • 5.1.2 How to Use This Section
      • Abionic: Study Demonstrates Diagnosis of Sepsis in 5 Minutes
      • T2 Biosystems Introduces New Data and Updates for Rapid Diagnostic Technology
      • Sepsis found to fit into 4 subtypes
      • GenMark Diagnostics Receives FDA Clearance for Blood Panel
      • Novacyt, Immunexpress Extend Sepsis Assay Development Partnership
      • New Test Could Diagnose Sepsis Faster
      • Immunexpress Wins $745K HHS Contract for Rapid Sepsis Assay
      • Curetis' Unyvero Application Cartridges Receive Regulatory Approvals
      • Luminex to Pay $75M for MilliporeSigma's Flow Cytometry Research Portfolio
      • Experimental 2.5-minute Sepsis Test Discovered
      • sphingotec raises €20 million
      • SeLux Diagnostics Announces Sepsi U.S. HHS/BARDA Research Funding
      • Roche PCT assay cleared as tool in fight against Sepsis
      • GeneFluidics selected as finalist for AMR Challenge
      • BioDirection, Inc. Announces System to Diagnose and Monitor Sepsis
      • sphingotec Adding Advanced POC Testing Platform
      • Rapid Detection Using DNAe's LiDia® Bloodstream Infection Technology
      • Septec Team Working on 15 Minute Sepsis Diagnosis
      • Abionic Announces Rapid Sepsis PoC Diagnostic

6. Profiles of Key Companies

  • Abbott Diagnostics
  • Abionic
  • Accel Diagnostics
  • Accelerate Diagnostics
  • Axis-Shield Diagnostics Ltd
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Biocartis
  • bioMérieux Diagnostics
  • Bio-Rad Laboratories, Inc.
  • Bruker
  • Cube Dx
  • Curetis N.V. / Curetis GmbH
  • Cytovale
  • EKF Diagnostics Holdings
  • GeneFluidics
  • GenMark Dx
  • Grifols
  • Immunexpress
  • Inflammatix
  • Linear Diagnostics
  • Luminex Corp
  • Mbio Diagnostics
  • Mobidiag
  • Nanomix
  • Qiagen Gmbh
  • Response Biomedical
  • Roche Molecular Diagnostics
  • SeLux Diagnostics
  • Septec
  • Siemens Healthineers
  • Sphingotec
  • T2 Biosystems
  • Thermo Fisher Scientific Inc

7. Sepsis Diagnostic Markets

  • 7.1 Sepsis Diagnostics - Global Market Overview by Country
    • 7.1.1 Table - Global Market by Country
    • 7.1.2 Chart - Global Market by Country

8. Global Sepsis Diagnostics Markets - By Assay Type

  • 8.1 Global Market by Diagnostic Type - Overview
    • 8.1.1 Table - Global Market by Diagnostic Type
    • 8.1.2 Chart - Global Market by Assay Type
    • 8.1.3 Chart - Global Market by Type - 2019
    • 8.1.4 Chart - Global Market by Type -2024
    • 8.1.4 Chart - Global Market by Type - Share by Year
  • 8.2 Sepsis Diagnostic - Microbiology
    • 8.2.1 Table Sepsis Diagnostic Microbiology - by Country
    • 8.2.2 Chart - Sepsis Diagnostic Microbiology Growth
  • 8.3 Sepsis Diagnostic - Syndromic PoC Panel
    • 8.3.1 Table Sepsis Diagnostic Syndromic PoC Panel - by Country
    • 8.3.2 Chart - Sepsis Diagnostic Syndromic PoC Panel Growth
  • 8.4 Sepsis Diagnostic - Other Infectious Disease
    • 8.4.1 Table Sepsis Diagnostic Other ID - by Country
    • 8.4.2 Chart - Sepsis Diagnostic - Other Infectious Disease Growth
  • 8.5 Sepsis Diagnostic - Biomarker Molecular Diagnostic
    • 8.5.1 Table Sepsis Diagnostic Biomarker MDx - by Country
    • 8.5.2 Chart - Sepsis Diagnostic - Biomarker MDx Growth
  • 8.6 Sepsis Diagnostic - Biomarker Other
    • 8.6.1 Table Sepsis Diagnostic Biomarker Other - by Country
    • 8.6.2 Chart - Sepsis Diagnostic - Biomarker Other Growth

9. Global Sepsis Diagnostics Markets - By Product Type

  • 9.1 Global Market by Product Type - Overview
    • 9.1.1 Table - Global Market by Product Type
    • 9.1.2 Chart - Global Market by Product Type - 2019/2024 Comparison
    • 9.1.3 Chart - Global Market by Product Type - Base Year
    • 9.1.4 Chart - Global Market by Product Type - Final Year
    • 9.1.4 Chart - Global Market by Product Type - Share by Year
  • 9.2 Sepsis Diagnostic - Instruments
    • 9.2.1 Table Sepsis Diagnostic Instruments - by Country
    • 9.2.2 Chart - Sepsis Diagnostic Instruments Growth
  • 9.3 Sepsis Diagnostic - Reagents
    • 9.3.1 Table Sepsis Diagnostic Reagents - by Country
    • 9.3.2 Chart - Sepsis Diagnostic Reagents Growth
  • 9.4 Sepsis Diagnostic - Software & Service
    • 9.4.1 Table Sepsis Diagnostic SW & Service - by Country
    • 9.4.2 Chart - Sepsis Diagnostic - SW & Services Growth

Appendices

  • I. United States Medicare System: 2019 Clinical Laboratory Fees Schedule - National Limit and Midpoint

Table of Tables

  • Table 1: Lab Spending 2014 to 2024
  • Table 2: sepsis biomarkers - Established and potential
  • Table 3: Market Players by Type
  • Table 4: Five Factors Driving Growth
  • Table 5: Three Factors Limiting Growth
  • TABLE 6: GLOBAL SEPSIS DIAGNOSTICS MARKET BY COUNTRY/REGION
  • TABLE 7: GLOBAL MARKET BY ASSAY TYPE
  • TABLE 8: SEPSIS DIAGNOSTIC MICROBIOLOGY BY COUNTRY
  • TABLE 9: SEPSIS DIAGNOSTIC SYNDROMIC POC PANEL BY COUNTRY
  • TABLE 10: SEPSIS DIAGNOSTIC OTHER ID BY COUNTRY
  • TABLE 11: SEPSIS DIAGNOSTIC BIOMARKER MDX BY COUNTRY
  • TABLE 12: SEPSIS DIAGNOSTIC BIOMARKER OTHER BY COUNTRY
  • TABLE 13: GLOBAL MARKET BY PRODUCT TYPE
  • TABLE 14: SEPSIS DIAGNOSTIC INSTRUMENTS BY COUNTRY
  • TABLE 15: SEPSIS DIAGNOSTIC REAGENTS BY COUNTRY
  • TABLE 16: SEPSIS DIAGNOSTIC SW & SERV BY COUNTRY
  • Table 17: 2019 Clinical Lab Fee Schedule

Table of Figures

  • Figure 1: Sepsis Survival graph
  • Figure 2: Percentage of Sepsis Patients with Comorbidity
  • Figure 3: Clinical Lab Spending 2014 to 2024
  • Figure 4: Sepsis Clinical Progression
  • Figure 5: Deaths From Drug Resistant Infections 2050
  • Figure 6: Aggregate Age of World Population
  • Figure 7: Growth in Health Care Spending Developing World
  • Figure 8: Comparing The New Diagnostics and Traditional Testing
  • Figure 9: Growth rates of Sepsis Diagnostics
  • Figure 10: Global Market Density Chart
  • Figure 11: Sepsis Diagnostics Market by Type - 2019 vs. 2024
  • FIGURE 12: SEPSIS DIAGNOSTICS MARKET 2019
  • FIGURE 13: SEPSIS DIAGNOSTICS MARKET 2024
  • FIGURE 14: TYPE SHARE BY YEAR
  • FIGURE 15: SEPSIS DIAGNOSTIC MICROBIOLOGY GROWTH
  • FIGURE 16: SEPSIS DIAGNOSTICS SYNDROMIC POC PANEL GROWTH
  • FIGURE 17: SEPSIS DIAGNOSTIC OTHER INFECTIOUS DISEASE GROWTH
  • FIGURE 18: SEPSIS DIAGNOSTIC MOLECULAR DIAGNOSTICS GROWTH
  • FIGURE 19: SEPSIS DIAGNOSTIC BIOMARKER OTHER GROWTH
  • Figure 20: Sepsis Diagnostics Market by Product Type - 2019 vs. 2024
  • FIGURE 21: SEPSIS DIAGNOSTICS MARKET BY PRODUCT TYPE BASE YEAR
  • FIGURE 22: SEPSIS DIAGNOSTICS MARKET BY PRODUCT TYPE FINAL YEAR
  • FIGURE 23: PRODUCT TYPE SHARE BY YEAR
  • FIGURE 24: SEPSIS DIAGNOSTIC INSTRUMENTS GROWTH
  • FIGURE 25: SEPSIS DIAGNOSTICS HBA1C GROWTH
  • FIGURE 26: SEPSIS DIAGNOSTIC SE & SERVICES GROWTH
Back to Top